For decades, menopause was a taboo subject. Now, it's a national conversation — and a growing market. The UK women's healthcare market report by MRFR shows that specialized care is the largest segment, but preventive care is the fastest‑growing. The market is $0.7 billion and will hit $1.64 billion by 2035, growing at 8.08% CAGR. Why the surge? Because women are demanding better care for menopause, endometriosis, and PCOS.

What's driving growth? Hormonal therapies are the largest pharmaceutical segment, but fertility treatments are the fastest‑growing. The UK women's healthcare market analysis highlights that diagnostic devices dominate the medical devices segment, but therapeutic devices are growing fast — as women seek non‑hormonal options for heavy bleeding and fibroids.

What's new? Digital menopause apps (e.g., Peppy, Stella) that offer evidence‑based advice and community support. Also, the NHS's Menopause Matters campaign, which has reduced stigma.

The bottom line: if you're struggling with menopause symptoms, don't suffer in silence. Talk to your GP. There are safe and effective treatments — from HRT to cognitive behavioural therapy.